





The American Association of Neurological Surgeons broadly 
defines cerebrovascular disease (CVD) as a “disorder in which 
an area of the brain is temporarily or permanently affected by 
ischaemia or bleeding and one or more of the cerebral blood 
vessels are involved in the pathological process.”(1) Thus, the 
definition of CVD encompasses stroke, carotid stenosis, ver-
tebral stenosis, intracranial stenosis, aneurysms, and vascular 
malformations.(1) Globally, CVDs represent an important cause 
of morbidity and mortality.(2) Although the burden of disease 
attributed to CVDs has traditionally been higher in industrialised 
nations, recent trends analyses suggest an increasing burden of 
CVDs in developing countries, including South Africa.(2) In fact, 
CVDs are now ranked the second most important cause of 
death in the country.(3) The steep increase in CVD-associated 
morbidity and mortality is likely attributable to rapid urbanisa-
tion and adoption of Westernised lifestyles by South Africans, 
coupled with a concomitant increase in CVD risk factors in the 
general population.(4,5) 
CVD is associated with considerable resource utilisation at 
South African public hospitals. An analysis of 195 stroke 
patients admitted to the GF Jooste Hospital in Cape Town 
during 2001 - 2002 revealed that patients stayed an average 
of 6.5 - 10.4 days in hospital depending on whether they 
were admitted to a general ward or a specialist stroke unit.(6) 
A descriptive study of inpatient 
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Length of stay contributes to most of the costs associated with 
stroke care. One South African study reported that stroke 
care amounts to R2.5 - 4.2-million in some sub-districts, with 
inpatient length of stay accounting for a large proportion of 
these costs.(7) Other aspects of CVD care, including medical, 
laboratory, and radiologic investigations, can also be very costly 
to the public health system.(7) Furthermore, CVD is associated 
with high levels of inpatient mortality at South African hospitals. 
An inpatient mortality rate of 16% - 33% was reported at the 
GF Jooste Hospital in Cape Town, depending on whether the 
patients were admitted to general ward or a specialist stroke 
unit.(6) A recent chart review of 136 stroke patients from a 
regional hospital in KwaZulu-Natal reported a lower, but still 
concerning inpatient mortality rate of 4%.(8) 
The consequences of CVD highlight the importance of pre-
ventative efforts across the disease continuum. Primary pre-
vention seeks to reduce the future risk of disease in individuals 
who are free from sub-clinical/clinical disease through health 
promotion and other risk reduction activities.(9-11) Secondary 
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Background: We sought to provide a descriptive report 
of inpatient admissions for cerebrovascular disease 
(CVD) at a tertiary hospital in KwaZulu-Natal, South 
Africa.  
Methods: We conducted a retrospective, descriptive 
study involving 1 017 patients admitted to the Inkosi 
Albert Luthuli Central Hospital for treatment of CVD 
during 2005 - 2015. Patients were identifi ed using the 
hospital’s electronic administrative system. Demo-
graphics, inpatient length of stay, surgical procedures, 
and survival status at discharge were also obtained for 
each patient. Descriptive statistics were used to analyse 
the data. 
Results: The median age of CVD patients was 50.0 years, 
and 50.4% were male. The median inpatient length of 
stay was 13.0 days. Surgery was performed in 38.8% of 
patients. The mortality rate was 22.5%. 
Conclusion: The resource burden that CVD places on 
tertiary healthcare services and the high mortality in 
affl icted patients highlights the need for effective pri-
mary and secondary prevention interventions in our 













prevention seeks to timeously identify those who have sub-
clinical disease and poorly controlled risk factors through 
screening processes.(9-11) In theory, individuals who are timeously 
screened and diagnosed with sub-clinical disease can be linked 
to treatment earlier, resulting in better clinical outcomes when 
compared with individuals who already demonstrate mani-
festations of clinical disease at the time of screening. Tertiary 
prevention applies to individuals who have clinical disease (i.e., 
those who have already suffered a stroke). The focus of tertiary 
prevention is effective management of existing clinical disease 
such that the risk of subsequent complications, including death, 
is greatly reduced.(9-11) Tertiary prevention often requires spe-
cialist inpatient medical/surgical services (tertiary-level care),(11) 
and is not offered at all hospitals in South Africa.(12) Tertiary-
level care is also very costly,(13) which is another important 
consideration in a resource-constrained country such as South 
Africa. 
We sought to improve our understanding around the impact 
that CVD has on specialist services in our resource-constrained 
setting by conducting a descriptive study of inpatient admissions 
for CVD at a tertiary-level hospital in KwaZulu-Natal, South 
Africa.
MATERIALS AND METHODS
Study design and setting
This was a retrospective, descriptive study of inpatient data 
collected at the Inkosi Albert Central Hospital (IALCH) in 
Durban, KwaZulu-Natal. The province of KwaZulu-Natal is 
located on the east coast of South Africa and is administratively 
divided into 11 district municipalities: Amajuba, eThekwini 
(which includes the City of Durban), Harry Gwala, iLembe, King 
Cetshwayo, Ugu, Umgungundlovu (which includes the City of 
Pietermaritzburg), Umkhanyakude, Umzinyathi, Uthukela, and 
Zululand. IALCH is a tertiary-level, public-sector hospital in 
KwaZulu-Natal and offers medical and surgical services in most 
of the major clinical specialties. Admission to IALCH is referral-
based, with most patients being referred from lower-level 
regional hospitals in the province. 
Study sample
Our study sample consisted of 1 017 adult patients who were 
admitted to IALCH for treatment of their CVD between 
1 January 2005 and 31 December 2015. 
Data collection
All patients comprising our study sample were identified from 
the IALCH electronic administrative system using International 
Classif ication of Diseases - Tenth Revision (ICD-10) primary 
diagnosis codes indicative of CVD (Table I). 




G45.0 Vertebro-basilar artery syndrome
G45.1 Carotid artery syndrome (hemispheric)
G45.8
Other transient cerebral ischaemic attacks and related 
syndromes
G45.9 Transient cerebral ischaemic attack, unspecifi ed
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
I60.1 Subarachnoid haemorrhage from middle cerebral artery
I60.2 Subarachnoid haemorrhage from anterior communicating artery
I60.3
Subarachnoid haemorrhage from posterior communicating 
artery
I60.4 Subarachnoid haemorrhage from basilar artery
I60.5 Subarachnoid haemorrhage from vertebral artery
I60.6 Subarachnoid haemorrhage from other intracranial arteries
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecifi ed
I60.8 Other subarachnoid haemorrhage
I60.9 Subarachnoid haemorrhage, unspecifi ed
I61 Intracerebral haemorrhage
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
I61.1 Intracerebral haemorrhage in hemisphere, cortical
I61.2 Intracerebral haemorrhage in hemisphere, unspecifi ed
I61.3 Intracerebral haemorrhage in brain stem
I61.4 Intracerebral haemorrhage in cerebellum
I61.5 Intracerebral haemorrhage, intraventricular
I61.6 Intracerebral haemorrhage, multiple localized
I61.8 Other intracerebral haemorrhage
I61.9 Intracerebral haemorrhage, unspecifi ed
I63.0 Cerebral infarction due to thrombosis of precerebral arteries
I63.2
Cerebral infarction due to unspecifi ed occlusion or stenosis of 
precerebral arteries 
I63.3 Cerebral infarction due to thrombosis of cerebral arteries
I63.4 Cerebral infarction due to embolism of cerebral arteries
I63.5
Cerebral infarction due to unspecifi ed occlusion or stenosis of 
cerebral arteries
I63.8 Other cerebral infarction
I63.9 Cerebral infarction, unspecifi ed
I64 Stroke, not specifi ed as haemorrhage or infarction
58
Other variables retrospectively extracted from the IALCH 
electronic administrative system for the purposes of our study 
included the patient’s age, gender, length of inpatient stay, 
surgical procedures, and survival status at discharge. We de-
identified the data extracted from the IALCH electronic admini-
strative system and saved this as a Microsoft Excel® spread-
sheet in preparation for the subsequent data analysis.
Data analysis
Descriptive statistics were used to summarise the characteris-
tics of our study sample. We calculated medians and interquar-
tile ranges for continuous variables, and frequencies and 
proportions for categorical variables. We performed the data 
analysis using R version 3.6.2 (R Foundation for Statistical 
Computing, Vienna, Austria). 
Ethical approval
Our study was part of a larger healthcare utilisation project 
at IALCH, which was approved by the Biomedical Research 
Ethics Committee at the University of KwaZulu-Natal (Protocol 
BE595/16). 
RESULTS
A description of our study sample is provided in Table II. The 
median age of our study sample was 50 years old, and there 
were similar proportions of males and females. The median 
length of stay was 13 days. There were 395 patients (38.8%) 
who received surgical intervention. Of those patients who 
received surgical intervention, 232 (58.7%) had neurosurgery, 
126 (31.9%) had vascular surgery, and 37 (9.4%) had other 
surgical procedures. There was a particularly high inpatient 
mortality rate (229 patients, 22.5%). 
INPATIENT CARE FOR CEREBROVASCULAR DISEASE
TABLE II: Description of the study sample (n=1 017).
Characteristic Summary statistic
Age, median in years (interquartile range) 50.0 (39.0-61.0)





Length of inpatient stay, median in days 
(interquartile range)
13.0 (8.0-21.0)










TABLE III: CVD by ICD-10 descriptions at IALCH, 
2005 - 2015.
ICD-10 description
n (% of 
n=1 017)
Vertebro-basilar artery syndrome 1 (0.1)
Carotid artery syndrome (hemispheric) 4 (0.4)
Other transient cerebral ischaemic attacks and 
related syndromes
9 (0.9)
Transient cerebral ischaemic attack, unspecifi ed 33 (3.2)
Subarachnoid haemorrhage from carotid siphon 
and bifurcation
4 (0.4)
Subarachnoid haemorrhage from middle 
cerebral artery
16 (1.6)
Subarachnoid haemorrhage from anterior 
communicating artery
36 (3.5)
Subarachnoid haemorrhage from posterior 
communicating artery
34 (3.3)
Subarachnoid haemorrhage from basilar artery 4 (0.4)
Subarachnoid haemorrhage from vertebral artery 2 (0.2)
Subarachnoid haemorrhage from other 
intracranial arteries
8 (0.8)
Subarachnoid haemorrhage from intracranial 
artery, unspecifi ed
17 (1.7)
Other subarachnoid haemorrhage 26 (2.6)
Subarachnoid haemorrhage, unspecifi ed 203 (20.0)
Intracerebral haemorrhage 1 (0.1)
Intracerebral haemorrhage in hemisphere, subcortical 9 (0.9)
Intracerebral haemorrhage in hemisphere, cortical 2 (0.2)
Intracerebral haemorrhage in hemisphere, unspecifi ed 7 (0.7)
Intracerebral haemorrhage in brain stem 7 (0.7)
Intracerebral haemorrhage in cerebellum 10 (1.0)
Intracerebral haemorrhage, intraventricular 140 (13.8)
Intracerebral haemorrhage, multiple localized 3 (0.3)
Other intracerebral haemorrhage 53 (5.2)
Intracerebral haemorrhage, unspecifi ed 107 (10.5)
Cerebral infarction due to thrombosis of 
precerebral arteries
1 (0.1)
Cerebral infarction due to unspecifi ed occlusion or 
stenosis of precerebral arteries
2 (0.2)
Cerebral infarction due to thrombosis of 
cerebral arteries
4 (0.4)
Cerebral infarction due to embolism of 
cerebral arteries
1 (0.1)
Cerebral infarction due to unspecifi ed occlusion or 
stenosis of cerebral arteries
14 (1.4)
Other cerebral infarction 57 (5.6)
Cerebral infarction, unspecifi ed 89 (8.8)













emergency department of a tertiary academic hospital in 
Johannesburg found that only 18.7% of CVD patients presented 
to hospital within the 4.5 hour therapeutic window for throm-
bolysis.(15) Unsurprisingly, clinical outcomes are far worse in 
patients who delay seeking healthcare for CVD when compared 
with patients who timeously present to a healthcare facility. 
While it might not be the only reason for patient-related delays 
in seeking healthcare for CVD, poor knowledge and aware-
ness of this condition in the general population is by far the 
most commonly cited reason.(15) There is poor knowledge and 
awareness of cardiovascular conditions, including heart disease 
and CVD, among the general South African population.(16) A 
clear understanding of CVD signs and symptoms would enable 
the condition to be recognised by afflicted patients or their 
families at an early stage. This would then facilitate timeous 
presentation to a healthcare facility, and hopefully a better 
clinical outcome for the afflicted patient. Therefore, improving 
knowledge and awareness around CVD signs and symptoms in 
the general South African population through well-designed 
primary prevention interventions should be made a priority by 
public health specialists. Suboptimal control of CVD risk factors 
can also impact long-term patient outcomes. If left untreated 
for an extended period of time, CVD risk factors such as hyper-
tension cause progressive damage which can lead to more 
severe CVD and a higher likelihood of significant morbidity or 
mortality.(17) The preponderance of patients with haemorrhagic 
CVD in our study points to hypertension being an important 
CVD risk factor in our South African setting.(18) Community-
based screening for hypertension in South Africa is well 
accepted, but challenges exist in linking newly diagnosed 
patients to treatment at healthcare facilities. A study of a 
community-based screening intervention conducted in rural 
KwaZulu-Natal found that only 26.9% of individuals diagnosed 
with hypertension accessed treatment within 2 years following 
their diagnosis.(19) Even when patients do access care, there is 
an additional challenge of ensuring optimal control of the CVD 
risk factor through treatment adherence. Adherence to hyper-
tensive medications in the general South African population is 
poor.(20) One way to address the challenge of breakdowns in 
linkage to care for individuals with CVD risk factors and 
improving treatment adherence is using community-based, 
peer-led interventions. Community healthcare workers have 
already been used in South Africa with great success to improve 
linkage to care and treatment adherence in persons with HIV 
infection,(21-23) and it is likely that a similar approach for CVD risk 
factors would improve secondary prevention for CVD and 
associated clinical outcomes in our setting.   
The three most common categories of CVD based on ICD-10 
code descriptions (Table III) were “Subarachnoid haemor-
rhage, unspecified” (203 patients, 20.0%), “Intracerebral haem-
orrhage, intraventricular” (140 patients, 13.8%), and “Stroke, 
not specif ied as haemorrhage or infarction” (113 patients, 
11.1%). 
DISCUSSION
The 2 most important findings from our study of CVD admis-
sions at a tertiary South African hospital were the duration of 
the inpatient length of stay (Median of 13.0 days) and the high 
mortality rate (22.5%). Our findings for patient age and gender 
are similar to those reported in other hospital-based studies 
of CVA in South Africa.(14) Our findings for the surgical inter-
vention rate are to be expected, considering that patients 
attending a tertiary level hospital often have complex, advanced 
disease which cannot be managed solely through medical (non-
surgical) therapy alone. 
The inpatient length of stay observed in our study (13.0 days) 
was outside the range reported in a prior study of CVA admis-
sions at the regional-level GF Jooste Hospital in Cape Town 
(range: 6.4 - 10.4 days).(6) The difference in observed inpatient 
length of stay between the 2 studies is likely due to the dif-
ference in patient profiles between tertiary and regional-level 
hospitals. Patients attending tertiary level facilities are more 
likely to have severe, complex disease than those attending 
lower-level facilities, which would require these complex cases 
to stay longer in hospital for specialist medical or surgical pro-
cedures and their subsequent rehabilitation. However, this can 
equate to a considerable financial burden that the South African 
public healthcare system must incur, if the cost of inpatient 
length of stay at a tertiary-level hospital is considered. There-
fore, from the point-of-view of the public healthcare sector, 
there is a clear financial incentive for effective primary and 
secondary prevention interventions addressing CVD in the 
general South African population. 
Although the mortality rate reported in our study (22.5%) was 
within the range reported in other hospital-based studies of 
CVD in South Africa (range: 4% - 33%),(6,8) it is still alarmingly 
high. We attribute this high mortality rate to patient-related 
delays in presentation for care and poorly controlled CVD risk 
factors in the general population. Patient-related delays in pre-
senting to a hospital following a CVD event can impact the 
effectiveness of current treatments or the eligibility of patients 
for these treatments.(8,15) A recent study conducted at the 
60
Our study was not without limitations. We analysed patient 
data collected at a single tertiary hospital, and our findings might 
not be generalisable to other hospitals in South Africa. We also 
identified patients with CVD based on the primary ICD-10 
diagnosis code listed for their admission, and there might have 
been some patients who were incorrectly coded as having 
CVD on the IALCH electronic administrative system. However, 
this is likely to be a small proportion of patients as our ICD-10 
coding department consistently reports its coding accuracy at 
90% - 95%. Lastly, we were unable to provide a report on 
patient comorbidities/risk factors for CVD and post-discharge 
mortality, as this data is not included in the IALCH electronic 
administrative system. 
In conclusion, our study provides an insight on the resource 
burden that CVD places on tertiary healthcare services in South 
Africa. We also found an alarmingly high mortality rate in 
patients admitted for treatment of CVD. Our research high-
lights the need for effective primary and secondary prevention 
interventions for CVD in our setting.
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MULTIPLE CHOICE QUESTIONS
1. Primary prevention seeks to:
A. Effectively manage existing clinical disease such that the risk of subsequent complications is greatly reduced.
B. Reduce the future risk of disease in individuals who are free from sub-clinical/clinical disease through health promotion.
C. Identify those who have sub-clinical disease and poorly controlled risk factors through screening processes.
D. All of the above.
2. Secondary prevention seeks to:
A. Identify those who have sub-clinical disease and poorly controlled risk factors through screening processes.
B. Reduce the future risk of disease in individuals who are free from sub-clinical/clinical disease through health promotion.
C. Effectively manage existing clinical disease such that the risk of subsequent complications is greatly reduced.
D. None of the above.
3. Tertiary-level care is:
A. Costly.
B. Usually involves specialist medical or surgical services.
C. Often centralised at certain public hospitals.
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